What DENDREON CORP's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Brophy Karen | VP, Human Resources | Feb 23 | Withheld — tax / exercise cost · F | −1,137 | $0.05 | −$56.9 | 32,575 |
| Brophy Karen | VP, Human Resources | Feb 23 | Withheld — tax / exercise cost · F | −20,217 | $0.05 | −$1.01K | 33,712 |
| Brophy Karen | VP, Human Resources | Feb 23 | Withheld — tax / exercise cost · F | −758 | $0.05 | −$37.9 | 53,929 |
| Pacheco Silvio | SVP, Sales and Marketing | Feb 23 | Withheld — tax / exercise cost · F | −1,925 | $0.05 | −$96.3 | 67,736 |
| Pacheco Silvio | SVP, Sales and Marketing | Feb 23 | Withheld — tax / exercise cost · F | −20,466 | $0.05 | −$1.02K | 69,661 |
| Pacheco Silvio | SVP, Sales and Marketing | Feb 23 | Withheld — tax / exercise cost · F | −5,777 | $0.05 | −$289 | 90,127 |
| Brophy Karen | VP, Human Resources | Feb 19 | Open-market sale · S | −3,823 | $0.07 | −$270 | 54,687 |
| Brophy Karen | VP, Human Resources | Feb 19 | Open-market sale · S | −2,309 | $0.07 | −$167 | 58,510 |
| Pacheco Silvio | SVP, Sales and Marketing | Feb 18 | Open-market sale · S | −3,222 | $0.07 | −$222 | 95,904 |
| Monteith William | EVP, Technical Operations | Feb 17 | Open-market sale · S | −96,690 | $0.08 | −$7.3K | 209,875 |
| Pacheco Silvio | SVP, Sales and Marketing | Feb 17 | Open-market sale · S | −2,500 | $0.08 | −$203 | 99,126 |
| Crotty Robert | EVP, General Counsel | Feb 17 | Open-market sale · S | −21,764 | $0.08 | −$1.77K | 97,855 |
| Sandler Andrew Seth | EVP, Chief Medical Officer | Feb 13 | Open-market sale · S | −105,925 | $0.09 | −$9.47K | 207,914 |
| Sandler Andrew Seth | EVP, Chief Medical Officer | Feb 13 | Open-market sale · S | −7,791 | $0.09 | −$704 | 313,839 |
| Cox Greg | EVP, CFO & Treasurer | Feb 13 | Open-market sale · S | −4,021 | $0.09 | −$372 | 177,754 |
| Cox Greg | EVP, CFO & Treasurer | Feb 13 | Open-market sale · S | −110,133 | $0.09 | −$10.1K | 181,775 |
| Monteith William | EVP, Technical Operations | Feb 13 | Open-market sale · S | −1,284 | $0.09 | −$112 | 306,565 |
| Crotty Robert | EVP, General Counsel | Jan 31 | Withheld — tax / exercise cost · F | −470 | $0.16 | −$75.2 | 119,619 |
| Cox Greg | VP, Interim CFO & Treasurer | Jan 20 | Withheld — tax / exercise cost · F | −193 | $0.17 | −$31.8 | 291,908 |
| Monteith William | EVP, Technical Operations | Jan 20 | Withheld — tax / exercise cost · F | −240 | $0.17 | −$39.6 | 307,849 |
Loading...